AngioDynamics Inc at JPMorgan Healthcare Conference Transcript
Hi, everyone. Thanks for joining us today. My name is Lili Lozada. I'm part of the med tech equity research team here at JPMorgan. After the presentation, the breakout will be in the Kent Room.
And without further ado, it's my pleasure to introduce CEO of AngioDynamics, Jim Clemmer.
Thank you. Good morning. Thank you for JPMorgan for a great conference and inviting us to join.
So let me remind you, this morning, during our presentation, we're going to give you some forward-looking statements. These are plans and ideas we have about our company and our marketplace. But as savvy investors know, we can't make any guarantees to what we're talking about today, so make sure you read carefully and understand what we're talking about.
So thanks for joining us. Let's share with you our evolution at AngioDynamics. And we are a company in transformation. And a lot of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
